These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience.
    Author: Bonnel RA, La Grenade L, Karwoski CB, Beitz JG.
    Journal: J Am Acad Dermatol; 2003 Feb; 48(2):294-6. PubMed ID: 12582408.
    Abstract:
    A total of 26 postmarketing cases of allergic contact dermatitis to doxepin 5% cream were reported to the Food and Drug Administration. Our findings suggest that allergic contact dermatitis was more common when treatment duration exceeded the recommended 8 days. Allergic contact dermatitis to doxepin cream should be considered in patients whose condition fails to improve or worsens with doxepin use.
    [Abstract] [Full Text] [Related] [New Search]